Deciphering microbiome and neuroactive immune gene interactions in schizophrenia

Area of Science:

• Neuroscience
• Immunology
• Microbiology

Background:

• The gut microbiome plays a role in various diseases.
• The gut-brain axis connects the gut microbiome to brain function.
• Imbalances in gut microbiota are linked to neurological disorders like schizophrenia.

Purpose of the Study:

• To explore the role of the gut microbiome in schizophrenia.
• To investigate the gut-brain axis in neuropsychiatric disorders.
• To understand how immune system genes interact with the microbiome in schizophrenia.

Main Methods:

• Literature review of existing studies.
• Analysis of the gut-brain axis in neurological and psychiatric conditions.
• Examination of genetic factors, particularly immune system genes, in relation to microbiome dysbiosis.

Main Results:

• Schizophrenia, major depression, Parkinson's disease, and multiple sclerosis share gut microbiome imbalances and systemic inflammation.
• Microbiome dysbiosis may directly influence disease symptoms and causes.
• Genetic susceptibility, especially involving immune system genes like MHC, interacts with microbiome dysbiosis to affect neurodevelopment and schizophrenia.

Conclusions:

• The interplay between the microbiome, immune gene susceptibility, and the gut-brain axis is crucial in schizophrenia etiology and progression.
• Microbiome dysbiosis can impact neurodevelopment, particularly in genetically predisposed individuals.
• Major histocompatibility complex (MHC) genes and complement pathway genes are key players in the gut-brain axis relevant to schizophrenia.